scholarly journals Postoperative hypothermia and surgical site infection following peritoneal insufflation with warm, humidified carbon dioxide during laparoscopic colorectal surgery: a cohort study with cost-effectiveness analysis

2016 ◽  
Vol 31 (4) ◽  
pp. 1923-1929 ◽  
Author(s):  
Sam E. Mason ◽  
James M. Kinross ◽  
Jane Hendricks ◽  
Thanjakumar H. Arulampalam
Keyword(s):  
Carbon Dioxide ◽  
Cohort Study ◽  
Cost Effectiveness ◽  
Colorectal Surgery ◽  
Surgical Site Infection ◽  
Laparoscopic Colorectal Surgery ◽  
Cost Effectiveness Analysis ◽  
Site Infection ◽  
Effectiveness Analysis

Cost-effectiveness analysis of three methods of surgical-site infection surveillance: Less is more

2020 ◽  
Vol 48 (10) ◽  
pp. 1220-1224
Author(s):  
Ghada Ahmed Abu-Sheasha ◽  
Ramez Naguib Bedwani ◽  
Medhat Mohamed Anwar ◽  
Omaima Gaber Yassine
Keyword(s):  
Cost Effectiveness ◽  
Surgical Site Infection ◽  
Cost Effectiveness Analysis ◽  
Site Infection ◽  
Less Is More ◽  
Effectiveness Analysis ◽  
Infection Surveillance

Adipositas-Chirurgie – Ist bariatrische Chirurgie kosteneffektiv?

2017 ◽  
Vol 22 (04) ◽  
pp. 182-183
Author(s):  
Cornelia Blaich
Keyword(s):  
Bariatric Surgery ◽  
Cohort Study ◽  
Cost Effectiveness ◽  
Electronic Health Records ◽  
Bariatrische Chirurgie ◽  
Cost Effectiveness Analysis ◽  
Health Records ◽  
Typ 2 Diabetes ◽  
Effectiveness Analysis ◽  
Electronic Health

Gulliford MC et al. Costs and Outcomes of Increasing Access to Bariatric Surgery: Cohort Study and Cost-Effectiveness Analysis Using Electronic Health Records. Value Health 2017; 20: 85–92 Ziele der bariatrischen Chirurgie bei Patienten mit morbider Adipositas sind neben der Gewichtsreduktion die Remission oder geringere Inzidenz eines Typ-2-Diabetes und eine Reduktion der Sterblichkeit. Die Autoren untersuchen in einer Kohortenstudie die Auswirkungen und Kosteneffektivität der bariatrischen Chirurgie im Vergleich zu einer nicht chirurgischen Behandlung der Adipositas.

Cost-Effectiveness of Preoperative Nasal Mupirocin Treatment in Preventing Surgical Site Infection in Patients Undergoing Total Hip and Knee Arthroplasty: A Cost-Effectiveness Analysis

2012 ◽  
Vol 33 (2) ◽  
pp. 152-159 ◽  
Author(s):  
Xan F. Courville ◽  
Ivan M. Tomek ◽  
Kathryn B. Kirkland ◽  
Marian Birhle ◽  
Stephen R. Kantor ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Decision Tree ◽  
Surgical Site Infection ◽  
Hypothetical Cohort ◽  
Preoperative Treatment ◽  
Site Infection ◽  
Tree Model ◽  
Effectiveness Analysis ◽  
Nasal Mupirocin ◽  
The Cost

Objective.To perform a cost-effectiveness analysis to evaluate preoperative use of mupirocin in patients with total joint arthroplasty (TJA).Design.Simple decision tree model.Setting.Outpatient TJA clinical setting.Participants.Hypothetical cohort of patients with TJA.Interventions.A simple decision tree model compared 3 strategies in a hypothetical cohort of patients with TJA: (1) obtaining preoperative screening cultures for all patients, followed by administration of mupirocin to patients with cultures positive for Staphylococcus aureus; (2) providing empirical preoperative treatment with mupirocin for all patients without screening; and (3) providing no preoperative treatment or screening. We assessed the costs and benefits over a 1-year period. Data inputs were obtained from a literature review and from our institution's internal data. Utilities were measured in quality-adjusted life-years, and costs were measured in 2005 US dollars.Main Outcome Measure.Incremental cost-effectiveness ratio.Results.The treat-all and screen-and-treat strategies both had lower costs and greater benefits, compared with the no-treatment strategy. Sensitivity analysis revealed that this result is stable even if the cost of mupirocin was over $100 and the cost of SSI ranged between $26,000 and $250,000. Treating all patients remains the best strategy when the prevalence of S. aureus carriers and surgical site infection is varied across plausible values as well as when the prevalence of mupirocin-resistant strains is high.Conclusions.Empirical treatment with mupirocin ointment or use of a screen-and-treat strategy before TJA is performed is a simple, safe, and cost-effective intervention that can reduce the risk of SSI. S. aureus decolonization with nasal mupirocin for patients undergoing TJA should be considered.Level of Evidence.Level II, economic and decision analysis.Infect Control Hosp Epidemiol 2012;33(2):152-159

Sign in / Sign up

Export Citation Format

Share Document